Three patients with RAS mutations presented overexpression of CRLF2 (ALL 020, ALL 027, and ALL 042, Figure 1, Table S1); however, it was not possible to obtain a complete characterization to be considered Ph-like cases. Here, CRLF2 is linked to acute lymphoblastic leukemia.